BACKGROUND: Cytokine induction of the enzyme indoleamine 2,3-dioxygenase (IDO) has been implicated in the development of major depressive disorder (MDD). IDO metabolizes tryptophan (TRP) into kynurenine (KYN), thereby decreasing TRP availability to the brain. KYN is further metabolized into several neurotoxins. The aims of this pilot were to examine possible relationships between plasma TRP, KYN, and 3-hydroxyanthranilic acid (3-HAA, neurotoxic metabolite) and striatal total choline (tCho, cell membrane turnover biomarker) in adolescents with MDD. We hypothesized that MDD adolescents would exhibit: i) positive correlations between KYN and 3-HAA and striatal tCho and a negative correlation between TRP and striatal tCho; and, ii) the anticipated correlations would be more pronounced in the melancholic subtype group. METHODS: Fourteen adolescents with MDD (seven with melancholic features) and six healthy controls were enrolled. Minimums of 6 weeks MDD duration and a severity score of 40 on the Children's Depression Rating Scale-Revised were required. All were scanned at 3T with MRI, multi-voxel 3-dimensional, high, 0.75 cm(3), spatial resolution proton magnetic resonance spectroscopic imaging. Striatal tCho concentrations were assessed using phantom replacement. Spearman correlation coefficients were Bonferroni-corrected. RESULTS: Positive correlations were found only in the melancholic group, between KYN and 3-HAA and tCho in the right caudate (r=0.93, p=0.03) and the left putamen (r=0.96, p=.006), respectively. CONCLUSIONS: These preliminary findings suggest a possible role of the KYN pathway in adolescent melancholic MDD. Larger studies should follow. Copyright 2009 Elsevier Inc. All rights reserved.
BACKGROUND:Cytokine induction of the enzyme indoleamine 2,3-dioxygenase (IDO) has been implicated in the development of major depressive disorder (MDD). IDO metabolizes tryptophan (TRP) into kynurenine (KYN), thereby decreasing TRP availability to the brain. KYN is further metabolized into several neurotoxins. The aims of this pilot were to examine possible relationships between plasma TRP, KYN, and 3-hydroxyanthranilic acid (3-HAA, neurotoxic metabolite) and striatal total choline (tCho, cell membrane turnover biomarker) in adolescents with MDD. We hypothesized that MDD adolescents would exhibit: i) positive correlations between KYN and 3-HAA and striatal tCho and a negative correlation between TRP and striatal tCho; and, ii) the anticipated correlations would be more pronounced in the melancholic subtype group. METHODS: Fourteen adolescents with MDD (seven with melancholic features) and six healthy controls were enrolled. Minimums of 6 weeks MDD duration and a severity score of 40 on the Children's DepressionRating Scale-Revised were required. All were scanned at 3T with MRI, multi-voxel 3-dimensional, high, 0.75 cm(3), spatial resolution proton magnetic resonance spectroscopic imaging. Striatal tChoconcentrations were assessed using phantom replacement. Spearman correlation coefficients were Bonferroni-corrected. RESULTS: Positive correlations were found only in the melancholic group, between KYN and 3-HAA and tCho in the right caudate (r=0.93, p=0.03) and the left putamen (r=0.96, p=.006), respectively. CONCLUSIONS: These preliminary findings suggest a possible role of the KYN pathway in adolescent melancholic MDD. Larger studies should follow. Copyright 2009 Elsevier Inc. All rights reserved.
Authors: R J Steingard; D A Yurgelun-Todd; J Hennen; J C Moore; C M Moore; K Vakili; A D Young; A Katic; W R Beardslee; P F Renshaw Journal: Biol Psychiatry Date: 2000-12-01 Impact factor: 13.382
Authors: Rejane G Tavares; Carla I Tasca; Candice E S Santos; Letícia B Alves; Lisiane O Porciúncula; Tatiana Emanuelli; Diogo O Souza Journal: Neurochem Int Date: 2002-06 Impact factor: 3.921
Authors: L E Goldstein; M C Leopold; X Huang; C S Atwood; A J Saunders; M Hartshorn; J T Lim; K Y Faget; J A Muffat; R C Scarpa; L T Chylack; E F Bowden; R E Tanzi; A I Bush Journal: Biochemistry Date: 2000-06-20 Impact factor: 3.162
Authors: Aye-Mu Myint; Yong Ku Kim; Robert Verkerk; Simon Scharpé; Harry Steinbusch; Brian Leonard Journal: J Affect Disord Date: 2006-09-06 Impact factor: 4.839
Authors: Acioly L T Lacerda; Mark A Nicoletti; Paolo Brambilla; Roberto B Sassi; Alan G Mallinger; Ellen Frank; David J Kupfer; Matcheri S Keshavan; Jair C Soares Journal: Psychiatry Res Date: 2003-11-30 Impact factor: 3.222
Authors: Gislaine Z Réus; Karen Jansen; Stephanie Titus; André F Carvalho; Vilma Gabbay; João Quevedo Journal: J Psychiatr Res Date: 2015-05-19 Impact factor: 4.791
Authors: Rachel D Freed; Lushna M Mehra; Daniel Laor; Manishkumar Patel; Carmen M Alonso; Seunghee Kim-Schulze; Vilma Gabbay Journal: World J Biol Psychiatry Date: 2018-08-16 Impact factor: 4.132
Authors: Adriana Di Martino; Damien A Fair; Clare Kelly; Theodore D Satterthwaite; F Xavier Castellanos; Moriah E Thomason; R Cameron Craddock; Beatriz Luna; Bennett L Leventhal; Xi-Nian Zuo; Michael P Milham Journal: Neuron Date: 2014-09-17 Impact factor: 17.173
Authors: Kailyn A L Bradley; Julia A C Case; Omar Khan; Thomas Ricart; Amira Hanna; Carmen M Alonso; Vilma Gabbay Journal: Psychiatry Res Date: 2015-04-01 Impact factor: 3.222
Authors: Vilma Gabbay; Rachel D Freed; Carmen M Alonso; Stefanie Senger; Jill Stadterman; Beth A Davison; Rachel G Klein Journal: J Clin Psychiatry Date: 2018-06-26 Impact factor: 4.384
Authors: Timothy B Meier; Jonathan Savitz; Rashmi Singh; T Kent Teague; Patrick S F Bellgowan Journal: J Neurotrauma Date: 2016-01-13 Impact factor: 5.269